SEC Form 4 · accession 0001179110-15-005614
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
A Robert D Bailey
Officer — Chief Legal Officer & Corp Sec
Period of report
Mar 17, 2015
Accepted (ET)
Mar 31, 2015 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F2,F3 | Mar 17, 2015 | A | 7 | — | A | 17,417 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 17, 2015, seven (7) shares of ACT common stock were credited to the Reporting Person's third party managed account following the merger of Allergan, Inc. with and into Actavis plc. These shares resulted from the conversion of 21 shares of Allergan Common Stock which were purchased for the Reporting Person's account by an independent third party manager without any instruction, advice or consent from the Reporting Person as to the underlying transaction.
- F2In connection with the merger of Allergan, Inc. with and into Actavis plc on March 17, 2015, each share of Allergan Common Stock held by the Reporting Person was exchanged for $129.22 in cash plus 0.3683 of an Actavis Ordinary Share.
- F3Includes 13,012 unvested restricted share units of Actavis plc.